Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11834669 Recombinant cytomegalovirus vectors as vaccines for tuberculosis

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Scott Hansen0

Aurelio M. Bonavia0

Guangwu Xu0

Thomas G. Evans0

Dominick J. Laddy0

Louis Picker0

Ravi Anantha0

Date of Patent

December 5, 2023

0

Patent Application Number

173655090

Date Filed

July 1, 2021

0

Patent Citations

US Patent 7749745 Viral vectors and their use in therapeutic methods

0

US Patent 8486414 Immunogenic compositions comprising

0

US Patent 7892564 Recombinant infectious laryngotracheitis virus and uses thereof

0

US Patent 9249427 Recombinant HCMV and RHCMV vectors and uses thereof

0

US Patent 6953661 Method of preventing transport of a neurotropic virus and identifying agents for achieving same

0

US Patent 7364893 Recombinant infectious laryngotracheitis virus and uses thereof

0

Patent Primary Examiner

0

CPC Code

C12N 2710/16143

0

0

0

0

0

0

0

0

...

Patent abstract

Disclosed herein are cytomegalovirus vectors encoding fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, cytomegalovirus vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11834669 Recombinant cytomegalovirus vectors as vaccines for tuberculosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.